Magid Abou‐Gharbia

Author

Magid Abou‐Gharbia

Also Known As

Abou-Gharbia, M., Abou-Gharbia, M.A., M ABOUGHARBIA, M Abou-Gharbia, M. A. ABOU‐GHARBIA, M. ABOU-GHARBIA, M. ABOU‐GHARBIA, M. Abou-Gharbia, M. Abou‐Gharbia, M.A Abou-Gharbia

218

Publications

4.1K

Citations

H-Index

121

Concepts

All Affiliations

Temple University Princeton University Women's Health Research Institute Tanta University University of Rochester

About

Magid Abou‐Gharbia is an author at Temple University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	41	2.3K
2	Natural Sciences	14	17	806
3	Engineering	4	4	103
4	Health Sciences	4	4	292
5	Humanities	1	1	18

Magid Abou‐Gharbia

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor Darlene C. Deecher, Chad E. Beyer, Grace H. Johnston, Journal of Pharmacology and Experimental Therapeutics	2006	377
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer Hanghang Zhang, Somnath Pandey, Meghan Travers, Cell Cancer GenomicsTumor SuppressorMedicineCell BiologyTumor Microenvironment	2018	221
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer Alison Kurimchak, Claude Shelton, Kelly Duncan, Cell Reports GynecologyCancer BiologyTumor BiologyOvarian CancerDrug Resistance	2016	199
Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization Hassan Elokdah, Magid Abou‐Gharbia, James K. Hennan, Journal of Medicinal Chemistry Pharmaceutical ScienceAntiparasitic AgentCardiovascular PharmacologyPharmacotherapyPharmaceutical Chemistry	2004	166
Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s Disease Robert Martone, Hua Zhou, Kevin Atchison, Journal of Pharmacology and Experimental Therapeutics	2009	157
Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens Chris P. Miller, Michael D. Collini, Bach D. Tran, Journal of Medicinal Chemistry Altmetric Attention ScoreOrganic ChemistryChemistryChemical BiologyPharmaceutical Chemistry	2001	137
Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade J. Steven Jacobsen, Thomas A. Comery, Robert Martone, Proceedings of the National Academy of Sciences Neurochemical BiomarkersSocial SciencesEnhanced ClearanceNeuroinflammationAlzheimer's Disease	2008	136
Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties Lee E. Schechter, Daniel L. Smith, Sharon Rosenzweig‐Lipson, Journal of Pharmacology and Experimental Therapeutics	2005	130
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities Benfang Helen Ruan, Kevin Pong, Flora Jow, Proceedings of the National Academy of Sciences Immunophilin LigandsCell DeathSynaptic SignalingNeuroinflammationMolecular Pharmacology	2007	111
Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease Scott C. Mayer, Anthony F. Kreft, Boyd L. Harrison, Journal of Medicinal Chemistry Stable Analogue 10Alzheimer ’Social SciencesNeuroinflammationAlzheimer's Disease	2008	109

Page 1